Latest profit margin for Johnson & Johnson: 21.48% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), JNJ shows a profit margin of 21.48%. That compares with 33.88% in the prior-year period — down 36.6% year over year. That is above the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, JNJ's profit margin is now 21.48% (was 33.88%) — a 36.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Johnson & Johnson is outperforming or lagging.
The Healthcare sector average profit margin is about 13.89%. Johnson & Johnson is at 21.48%, which is higher that average. That is roughly 54.7% above the sector mean. Use the comparison chart on this page to see how JNJ stacks up against individual peers as well.
That compares with 33.88% in the prior-year period — down 36.6% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Johnson & Johnson with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Johnson & Johnson's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 21.48%) with ownership activity and broader fundamentals.